Nuvisan is a European full-service CRO located in Germany and France, part of the ALS Group, supporting pharmaceutical and biotech clients from early drug discovery through clinical development.

​

DMPK & ADME Expertise

Nuvisan offers a comprehensive portfolio of DMPK and ADME services, including:

• In vitro & in vivo DMPK

• Biotransformation & metabolite identification

• GLP-compliant bioanalysis

• Isotope chemistry ([14C]-& [3H]-radiosynthesis)

• DMPK consultancy

Nuvisan's integrated approach delivers the critical pharmacokinetic insights needed to confidently advance drug candidates through each stage of development.